Meet Our Team

Michael Benatar, MD, PhD

University of Miami Miller School of Medicine

Miami, FL

Consortium Principal Investigator
Project 1 Leader
Project 4 Co-leader
 

Expertise: Amyotrophic lateral sclerosis, myasthenia gravis, biomarkers, clinical trials, pre-symptomatic disease

Lindsay Alfano, DPT

Nationwide Children's Hospital

Columbus, OH

Project 4 Leader

Expertise: Physical therapy, outcome measure development, multi-system proteinopathy

Nicholas Ashton, PhD

Banner Health

Phoenix, AZ

Project 3 Leader

Expertise: Neurochemistry, biomarker development

Corey McMillan, PhD

University of Pennsylvania Perlman School of Medicine

Philadelphia, PA

Project 3 Leader

Expertise: Neurodegeneration, neuroimaging, biomarkers, frontotemporal degeneration (FTD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS)

Tahseen Mozafar, MD

University of California Irvine

Irvine, CA

Project 4 Co-leader

Expertise: Inclusion body myositis, muscle disease, ALS, multi-system proteinopathy, neuromuscular pathology

Michael Shy, MD

University of Iowa

Iowa City, IA

Principal Investigator

Expertise: Neuromuscular diseases, neuropathies, Charcot-Marie-Tooth disease, inherited neuropathies, clinical trials

Marka Van Blitterswijk, MD, PhD

Mayo Clinic

Jacksonville, FL

Project 2 Leader

Expertise: Amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), neurogenetics

Conrad Chris Weihl, MD, PhD

Washington University

St. Louis, MO

Project 4 Co-leader

Expertise: Inclusion body myositis, muscular dystrophies, myopathy, multi-system proteinopathy

Gang Wu, PhD

St. Jude Children's Research Hospital

Memphis, TN

Project 2 Leader

Expertise: Amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), neurogenetics